» Articles » PMID: 30627640

Adenosine Signaling Through A1 Receptors Inhibits Chemosensitive Neurons in the Retrotrapezoid Nucleus

Overview
Journal eNeuro
Specialty Neurology
Date 2019 Jan 11
PMID 30627640
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A subset of neurons in the retrotrapezoid nucleus (RTN) function as respiratory chemoreceptors by regulating depth and frequency of breathing in response to changes in tissue CO/H. The activity of chemosensitive RTN neurons is also subject to modulation by CO/H-dependent purinergic signaling. However, mechanisms contributing to purinergic regulation of RTN chemoreceptors are not entirely clear. Recent evidence suggests adenosine inhibits RTN chemoreception by activation of A1 receptors. The goal of this study was to characterize effects of adenosine on chemosensitive RTN neurons and identify intrinsic and synaptic mechanisms underlying this response. Cell-attached recordings from RTN chemoreceptors in slices from rat or wild-type mouse pups (mixed sex) show that exposure to adenosine (1 µM) inhibits chemoreceptor activity by an A1 receptor-dependent mechanism. However, exposure to a selective A1 receptor antagonist (8-cyclopentyl-1,3-dipropylxanthine, DPCPX; 30 nM) alone did not potentiate CO/H-stimulated activity, suggesting activation of A1 receptors does not limit chemoreceptor activity under these reduced conditions. Whole-cell voltage-clamp from chemosensitive RTN neurons shows that exposure to adenosine activated an inward rectifying K conductance, and at the network level, adenosine preferentially decreased frequency of EPSCs but not IPSCs. These results show that adenosine activation of A1 receptors inhibits chemosensitive RTN neurons by direct activation of a G-protein-regulated inward-rectifier K (GIRK)-like conductance, and presynaptically, by suppression of excitatory synaptic input to chemoreceptors.

Citing Articles

Update on vascular control of central chemoreceptors.

Moreira T, Mulkey D, Takakura A Exp Physiol. 2023; 109(11):1837-1843.

PMID: 38153366 PMC: 11522829. DOI: 10.1113/EP091329.


Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression.

Cleary C, James S, Maher B, Mulkey D Nat Commun. 2021; 12(1):5962.

PMID: 34645823 PMC: 8514575. DOI: 10.1038/s41467-021-26263-2.


The Good, the Bad, and the Deadly: Adenosinergic Mechanisms Underlying Sudden Unexpected Death in Epilepsy.

Purnell B, Murugan M, Jani R, Boison D Front Neurosci. 2021; 15:708304.

PMID: 34321997 PMC: 8311182. DOI: 10.3389/fnins.2021.708304.


The retrotrapezoid nucleus and the neuromodulation of breathing.

Moreira T, Sobrinho C, Falquetto B, Oliveira L, Lima J, Mulkey D J Neurophysiol. 2021; 125(3):699-719.

PMID: 33427575 PMC: 7988753. DOI: 10.1152/jn.00497.2020.


Take a deep breath and wake up: The protean role of serotonin preventing sudden death in infancy.

Cummings K, Leiter J Exp Neurol. 2019; 326:113165.

PMID: 31887304 PMC: 6956249. DOI: 10.1016/j.expneurol.2019.113165.


References
1.
Thomas T, Spyer K . A novel influence of adenosine on ongoing activity in rat rostral ventrolateral medulla. Neuroscience. 1999; 88(4):1213-23. DOI: 10.1016/s0306-4522(98)00296-6. View

2.
Cunha R . Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int. 2001; 38(2):107-25. DOI: 10.1016/s0197-0186(00)00034-6. View

3.
Dunwiddie T, Masino S . The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001; 24:31-55. DOI: 10.1146/annurev.neuro.24.1.31. View

4.
Mulkey D, Henderson 3rd R, Olson J, Putnam R, Dean J . Oxygen measurements in brain stem slices exposed to normobaric hyperoxia and hyperbaric oxygen. J Appl Physiol (1985). 2001; 90(5):1887-99. DOI: 10.1152/jappl.2001.90.5.1887. View

5.
Etherington L, Frenguelli B . Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. Eur J Neurosci. 2004; 19(9):2539-50. DOI: 10.1111/j.0953-816X.2004.03355.x. View